Home/ Supplements/ Electrolytes/ Calcium Hydroxyapatite Concentrate 275 m...

Calcium Hydroxyapatite Concentrate 275 mg

product on market Capsule Woodstock Vitamins Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Calcium and phosphorus provided via microcrystalline hydroxyapatite and MCHC are essential minerals for bone mineralization and structural integrity. Research indicates these ingredients support skeletal health, though evidence coverage for this specific formulation is limited. The profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Calcium Hydroxyapatite Concentrate 275 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Mineral
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
550 mg (55% DV)
198 mg (20% DV)
Within RDA (0.3× RDA) 13 studies (A:0, B:3)
MCHC
2.2 Gram(s)
Microcrystalline Hydroxyapatite
1.32 Gram(s)

Other Ingredients

HPMC Vegetable Stearic Acid Medium-Chain Triglycerides Microcrystalline Cellulose Vegetable Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one to two capsules up to two times daily, or as directed by your healthcare practitioner.

Warnings & Precautions

Consult your healthcare practitioner prior to use.

Individuals taking medication should discuss potential interactions with their healthcare practitioner.

Do not use if tamper seal is damaged.

The labeling on this product does not comply with California’s Proposition 65. Therefore, this product may not be sold in California.

Storage: Keep tightly closed in a cool, dry place out of reach of children.

Formulation Notes

Calcium Hydroxyapatite Concentrate 275 mg is a well-researched, standardized extract from one of the world’s safest premium sources of bone – free range New Zealand cattle.

Calcium Hydroxyapatite Concentrate 275 mg contains microcrystalline hydroxyapatite concentrate (MCHC), a complex crystalline compound composed primarily of calcium, phosphorus, bioactive growth factors, type l collagen, amino acids, glycosaminoglycans, and a broad range of essential trace elements that naturally comprise healthy bone.

Does not contain: Wheat, gluten, corn, yeast, soy, dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.

Manufactured in a GMP compliant facility.

Vegetarian caps

Additional Information

Storage: Keep tightly closed in a cool, dry place out of reach of children.

Professional use only.

Vegetarian caps

This package is completely recyclable.

Metadata

Product Details

UPC / SKU6 69439 85730 4
DSLD Entry Date2022-04-11
Product TypeMineral
FormCapsule
DSLD ID262999
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.